Announcement PDF 29 November 2023 Market Announcements Office Australian Securities Exchange Limited 20 Bridge Street SYDNEY NSW 2000 Re: Paradigm Biopharmaceuticals Limited (PAR) - Results of 2023 Annual General Meeting To: Australian Securities Exchange In accordance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act 2001 (Cth), the attached information is provided in relation to the resolutions passed by the shareholders of Paradigm Biopharmaceuticals Limited at its Annual General Meeting held on 29 November 2023. Authorised for release by the Board of Directors. Regards Abby Macnish Niven Company Secretary Paradigm Biopharmaceuticals Limited AUSTRALIA (Head Office) Paradigm Biopharmaceuticals Limited Level 15, 500 Collins St Melbourne, Victoria 3000 USA Paradigm Biopharmaceuticals (USA) Inc 31 West 34th St, 8th Floor New York, New York 10001 IRELAND Paradigm Biopharmaceuticals (Ireland) Limited Trinity House, Charleston Road Ranelagh, Dublin 6 paradigmbiopharma.com | info@paradigmbiopharma.com Disclosure of Proxy Votes Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Paradigm Biopharmaceuticals Limited Annual General Meeting Wednesday, 29 November 2023 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Poll Results (if applicable) Proxy Votes Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed 1 ADOPTION OF REMUNERATION REPORT P 66,067,877 2 RE-ELECTION OF DIRECTOR – DR DONNA SKERRETT P 108,612,536 3 APPROVAL OF 7.1A MANDATE P 109,353,965 4 ADOPTION OF EMPLOYEE PERFORMANCE RIGHTS PLAN P 86,379,090 5 ISSUE OF INCENTIVE PERFORMANCE RIGHTS TO DR DONNA SKERRETT P 89,092,894 6 ISSUE OF INCENTIVE PERFORMANCE RIGHTS TO MR PAUL RENNIE P 88,339,104 7 AMENDMENT TO CONSTITUTION P 109,060,774 8 RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES P 35,580,257 FOR AGAINST 50,133,147 14,626,425 75.88% 22.14% 88,447,660 19,004,208 81.43% 17.50% 72,308,338 35,714,354 66.12% 32.66% 66,651,839 18,603,866 77.16% 21.54% 68,310,954 19,636,999 76.67% 22.04% 65,479,141 21,758,395 74.12% 24.63% 57,995,052 49,738,129 53.18% 45.61% 30,696,682 4,554,578 86.27% 12.80% ABSTAIN 23,433,125 1,867,271 2,220,126 1,023,183 408,108 1,161,898 2,513,317 3,141,252 PROXY'S DISCRETION FOR AGAINST 1,308,305 57,175,753 19,400,622 1.98% 74.67% 25.33% 1,160,668 100,989,021 19,579,434 1.07% 83.76% 16.24% 1,331,273 78,988,347 41,845,537 1.22% 65.37% 34.63% 1,123,385 78,141,529 18,841,993 1.30% 80.57% 19.43% 1,144,941 80,781,677 19,777,136 1.29% 80.33% 19.67% 1,101,568 73,377,654 26,427,369 1.25% 73.52% 26.48% 1,327,593 64,438,410 56,064,312 1.22% 53.47% 46.53% 328,997 43,773,939 5,139,015 0.92% 89.49% 10.51% Results ABSTAIN OUTCOME 24,379,321 - 1,377,271 Passed 2,206,126 Not Passed 1,023,183 Passed 408,108 Passed 1,161,898 Passed 2,537,288 Not Passed 3,103,056 Passed Poll Results (if applicable) Proxy Votes Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed 9 APPROVAL TO ISSUE ATTACHING OPTIONS P 39,482,487 10 APPROVAL TO ISSUE SUB-UNDERWRITER OPTIONS P 99,170,593 FOR AGAINST 30,694,097 8,459,193 77.74% 21.43% 92,144,821 6,687,450 92.92% 6.74% ABSTAIN 17,155,236 2,895,249 PROXY'S DISCRETION FOR AGAINST 329,197 43,711,015 9,055,169 0.83% 82.84% 17.16% 338,322 104,209,999 7,257,426 0.34% 93.49% 6.51% ABSTAIN Results OUTCOME 17,166,040 Passed 3,016,053 Passed